For other AOMs, it is suggested to stop treatment if weight loss of more than 5% has not been achieved after 12 weeks of treatment [9]
Characteristics were compared between patients with and without DM using the independent t-test for continuous variables and the chi-square test for dichotomous variables
Dosing Strategies Extended-release alpha agonists Take 2-4 weeks for full effect
Por1 couples the glutathione pools of the IMS and the cytosol The cytosol and IMS are separated by the OMM, which contains porins as the major gateways for the exchange of small molecules
The dosage chart presented here provides a framework, but the clinical nuances, specifically the titration pace, the dose ceiling, the choice of synergistic agents, and the biomarker monitoring schedule, should be individualized by a physician familiar with both the patient's metabolic history and the evolving evidence base for mitochondrial peptide therapy